Saku’s core objective is to commercialize manufacturing-grade, producer host cell products for use by CDMOs and biotechnology companies.
Saku’s host cells are designed to improve three core levers of biological manufacturing economics:
Productivity-
Higher titers reduce required reactor volume, capital intensity, batch counts, and operating costs. Improvements at the cell level compound dramatically at commercial scale, improving unit economics and throughput.
Feedstock Flexibility and Supply Chain Resilience-
Most production hosts are optimized around narrow, expensive feedstocks. This constrains geographic flexibility, increases exposure to commodity price volatility, and limits the ability to localize production. Host cells that can efficiently utilize alternative or regionally available feedstocks unlock lower input costs and more resilient supply chains.
Downstream Processing Complexity-
Cell physiology directly affects impurity profiles, secretion efficiency, and byproduct formation. Poorly optimized hosts increase downstream burden, which often represents a majority of total cost of goods. Improvements at the host cell level can materially simplify purification and reduce downstream capital and operating costs.
Because host cells sit at the foundation of the manufacturing stack, improvements at this level create significant economic impact.